首页> 外国专利> INHIBITORS OF N-TERMINAL KINASES C-JUN (JNK) AND OTHER KINASE PROTEINS.

INHIBITORS OF N-TERMINAL KINASES C-JUN (JNK) AND OTHER KINASE PROTEINS.

机译:N末端激酶C-JUN(JNK)和其他激酶蛋白的抑制剂。

摘要

A compound of formula I or II: (See formula) or a pharmaceutically acceptable salt thereof, where: each W is independently selected from nitrogen or CH; R 1, R 2 and R 3 are independently selected from OH, OCH3, OCH2CH3, NHCOMe, NH2, NH (C1-4 aliphatic group), N (C1-4 aliphatic group) 2, O (CH2) 2morpholin-4-yl , O (CH2) 2NH2, O (CH2) 2NH (C1-4 aliphatic group), O (CH2) 2N (C1-4 aliphatic group) 2, bromine, chlorine or fluorine; or (See formula) R 1 and R 2 or R 2 and R 3 taken together to form R 4 is a phenyl, cyclohexyl, naphthyl, pyridyl, pyrimidinyl, triazinyl, thiazolyl, thiadiazolyl, pyrazolyl, isoxazolyl, indazolyl or substituted benzimidazolyl ring ; wherein said ring is substituted with 1-2 groups independently selected from chlorine, fluorine, bromine, methyl, ethyl, t-butyl, isopropyl, cyclopropyl, CF3, NH2, benzyl, benzyloxy, OH-, methylenedioxy, SO2NH2, phenoxy, O- pyridinyl, SO2fenilo, nitrophenoxy, aminophenoxy, S-dimethylpyrimidine, NH-phenyl, NH-methoxyphenyl, pyridinyl, aminophenyl, phenol, chloro-fluorophenyl, dimethylaminophenyl, CF3-phenyl, dimethylphenyl, chlorophenyl, fluorophenyl, methoxyphenoxy, chlorophenoxy, ethoxyphenoxy or fluorophenoxy; with the proviso that: said compound is different from a compound of formula III (See formula)
机译:式I或II的化合物:(参见式)或其药学上可接受的盐,其中:每个W独立地选自氮或CH; R 1,R 2和R 3独立地选自OH,OCH3,OCH2CH3,NHCOMe,NH2,NH(C1-4脂族基),N(C1-4脂族基)2,O(CH2)2吗啉-4-基,O(CH 2)2 NH 2,O(CH 2)2 NH(C 1-4脂族基),O(CH 2)2 N(C 1-4脂族基)2,溴,氯或氟;或(参见式)R 1和R 2或R 2和R 3一起形成R 4的是苯基,环己基,萘基,吡啶基,嘧啶基,三嗪基,噻唑基,噻二唑基,吡唑基,异恶唑基,吲唑基或取代的苯并咪唑基环;其中所述环被1-2个独立地选自氯,氟,溴,甲基,乙基,叔丁基,异丙基,环丙基,CF3,NH2,苄基,苄氧基,OH-,亚甲基二氧基,SO2NH2,苯氧基,O-的1-2个基团取代吡啶基,SO 2苯并,硝基苯氧基,氨基苯氧基,S-二甲基嘧啶,NH-苯基,NH-甲氧基苯基,吡啶基,氨基苯基,苯酚,氯氟苯基,二甲基氨基苯基,CF 3-苯基,二甲基苯基,氯苯基,氟苯基,甲氧基苯氧基,氯苯氧基,乙氧基苯氧基或氟苯氧基;条件是:所述化合物不同于式III化合物(参见式)

著录项

  • 公开/公告号ES2292753T3

    专利类型

  • 公开/公告日2008-03-16

    原文格式PDF

  • 申请/专利权人 VERTEX PHARMACEUTICALS INCORPORATED;

    申请/专利号ES20020725391T

  • 申请日2002-03-28

  • 分类号C07D405/04;A61K31/4418;A61K31/505;A61K31/506;A61K31/5377;A61K45;A61P1/04;A61P3/10;A61P3/14;A61P5/14;A61P7/02;A61P9;A61P9/04;A61P9/10;A61P11;A61P11/06;A61P17;A61P17/06;A61P17/08;A61P17/14;A61P19/02;A61P19/08;A61P19/10;A61P21/04;A61P25;A61P25/14;A61P25/16;A61P25/18;A61P25/28;A61P27/16;A61P29;A61P35;A61P37;A61P37/02;A61P37/06;A61P43;C07D213/74;C07D239/42;C07D401/12;C07D401/14;C07D403/04;C07D403/12;C07D413/12;C07D417/04;C07D417/12;

  • 国家 ES

  • 入库时间 2022-08-21 20:04:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号